Poland· PL-100033953
PoltechDMSA
A 99mtc-technetium-succimer product containing technetiii (99mtc) succimeri solutio iniectabilis, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
99mtc-technetium-succimer is registered in 8 of 19 countries.
Countries holding a registration under ATC V09CA02 (99mtc-technetium-succimer), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
99mtc-technetium-succimer · ATC V09CA02
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Technetiii (99mTc) succimeri solutio iniectabilis
- Manufacturer
- Narodowe Centrum Badań Jądrowych
- Country
- Poland (PL)
- ATC code
- V09CA02
- ATC class
- 99mTc-Technetium-Succimer
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990344024
- gtin05909990344017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09CA02
99mtc-technetium-succimer, as other registers publish it.
- FinlandAmerscan Techetium Dmsa AgentGE Healthcare Limited
- FinlandDmsatecAmersham Health S.r.l.
- FinlandIfe-DmsaIsopharma AS
- FinlandRenocisCIS bio international
- DenmarkRenocisCis Bio International
- IrelandRENOCIS 1 mg kit for radiopharmaceutical preparationCIS bio International
- FinlandTechnescan DMSACurium Netherlands B.V.
- DenmarkTechnescan DMSACurium Netherlands B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e56fd08-fb58-4698-9a40-3dc45daf27c3 GET /v1/drugs/1e56fd08-fb58-4698-9a40-3dc45daf27c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zestaw do sporządzania preparatu radiofarmaceutycznego",
"source": "urpl",
"strength": "1 mg DMSA",
"packaging": "Lz ¦ Skasowane ¦ 5311\n1 zestaw \n05909990344024 ¦ Lz ¦ 16445\n6 fiol. 10 ml\n05909990344017 ¦ Lz ¦ 54625\n3 fiol. 10 ml",
"substance": null,
"common_name": "Technetiii (99mTc) succimeri solutio iniectabilis",
"pl_product_id": "100033953",
"pozwolenie_nr": "03440",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about 99mtc-technetium-succimer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.